Skip to content
value.today

Cesca Therapeutics Inc.

Total raised
$33 M
3 rounds on record
Latest round
$3 M
Mar 2023
First round on record
Aug 2014
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Cesca Therapeutics Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2023$3 MNo. 3$2 to $10 million

Cesca Therapeutics Inc.: Raise no. 3, Mar 2023

Investors in this round

1 investor had bought by the notice of Mar 28, 2023: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$300,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Haihong Zhu · Executive Officer, Director · Chief Operating Officer
  • Jeffery Cauble · Executive Officer · Chief Financial Officer
  • Xiaochun Xu · Executive Officer, Director · Chief Executive Officer and Chairman of the Board
  • Joseph Thomis · Director
  • Russell Medford · Director
  • Vivian Liu · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • H.C. Wainwright & Co., LLC. (CRD 375) · New York, New YorkSold in NY

Signed by Jeffery Cauble, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 28, 2023. Read the notice at the SEC.

equity, optionsSEC
Feb 2016$15 MNo. 2$10 to $50 million

Cesca Therapeutics Inc.: Raise no. 2, Feb 2016

Investors in this round

2 investors had bought by the notice of Feb 26, 2016: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Common Stock; Convertible Debentures; Warrants to Purchase Shares of Common Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Bruch · Executive Officer · Chief Financial Officer
  • Robin Stracey · Executive Officer, Director · Chief Executive Officer and Director
  • Craig W. Moore · Director · Chairman of the Board
  • Denis Michael Rhein · Director
  • Mahendra S. Rao · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Bruch, Chief Financial Officer. Source: SEC Form D, newest notice filed Feb 26, 2016. Read the notice at the SEC.

equity, debt, optionsSEC
Aug 2014$15 MNo. 1$10 to $50 million

Cesca Therapeutics Inc.: Raise no. 1, Aug 2014

Investors in this round

2 investors had bought by the notice of Sep 15, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $15 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,200,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kenneth C Pappa · Executive Officer
  • Kenneth W Harris · Executive Officer, Director
  • Mike C Bruch · Executive Officer
  • Mitchel C Sivilotti · Executive Officer
  • Robin C Stacey · Executive Officer, Director
  • Craig W Moore · Director
  • Mahendra W Rao · Director
  • Michael C Rhein · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in NJ

Remarks in the notice

  • On fees: “8% of the total offering amount”

Signed by Mike Bruch, Cfo. Source: SEC Form D, newest notice filed Sep 15, 2015. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Cesca Therapeutics Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2023).

    SEC Form D · Mar 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2023

That is all the official record says: Cesca Therapeutics Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Cesca Therapeutics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 2 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Cesca Therapeutics Inc.
NameRoleNamed in
Haihong ZhuChief Operating OfficerMar 2023
Jeffery CaubleChief Financial OfficerMar 2023
Xiaochun XuChief Executive Officer and Chairman of the BoardMar 2023
Michael BruchChief Financial OfficerFeb 2016
Robin StraceyChief Executive Officer and DirectorFeb 2016
Kenneth C PappaExecutive officerSep 2015
Kenneth W HarrisExecutive officerSep 2015
Mike C BruchExecutive officerSep 2015
Mitchel C SivilottiExecutive officerSep 2015
Robin C StaceyExecutive officerSep 2015
Haihong ZhuChief Operating OfficerMar 2023
Joseph ThomisDirectorMar 2023
Russell MedfordDirectorMar 2023
Vivian LiuDirectorMar 2023
Xiaochun XuChief Executive Officer and Chairman of the BoardMar 2023
Craig W. MooreChairman of the BoardFeb 2016
Denis Michael RheinDirectorFeb 2016
Mahendra S. RaoDirectorFeb 2016
Robin StraceyChief Executive Officer and DirectorFeb 2016
Craig W MooreDirectorSep 2015
Kenneth W HarrisDirectorSep 2015
Mahendra W RaoDirectorSep 2015
Michael C RheinDirectorSep 2015
Robin C StaceyDirectorSep 2015